Skip to content
Cosmetic Peat
Association
← Research library

Biological Activity of Fulvic Acid: Prospects of Application in Medicine

review Grade C 2022 Language: ru Open access
Authors: Benderskiy, N.S., Safronenko, A.V., Kudelina, O.M., Gantsgorn, E.V., Krishtopa, A.V., Golubeva, A.O., Babyuk, S.E.
Journal: Journal Biomed (Биомедицина) 18 (3) : 79-83
DOI: 10.33647/2074-5982-18-3-79-83
View original study →

Key Findings

  • Fulvic acid anti-inflammatory and antiallergic properties relevant to eczema and bronchial asthma
  • FA promotes overexpression of IL-10 (anti-inflammatory cytokine) accelerating wound healing
  • Carbohydrate-derived fulvic acid demonstrated safe compound with anti-inflammatory and wound healing properties in rats
  • FA antioxidant activity attributed to oxygen reactive binding capacity
  • FA promotes Nrf2 transcription factor function and its coding proteins for wound healing via oxidative stress protection

Russian-language review published in the journal Biomed (2022), summarising fulvic acid’s pharmacological properties and medical applications. Authored by a team from Rostov-on-Don (Russia), the paper provides a useful post-2020 synthesis of FA evidence from the Russian-language literature alongside international sources.

Key Mechanisms Covered

The review focusses on three intersecting properties:

Anti-inflammatory and antiallergic — FA suppresses inflammatory mediators relevant to eczema, allergic rhinitis, and bronchial asthma. The antiallergic property connects to Yamada 2007’s finding that FA inhibits mast cell degranulation and histamine release.

Wound healing — FA promotes overexpression of IL-10, the anti-inflammatory cytokine that signals tissue repair transitions. It also activates the Nrf2 transcription factor and its downstream proteins, which regulate cellular responses to oxidative stress during wound healing. These mechanisms were independently confirmed in Samiee-Rad 2022 using a rat wound model.

Antioxidant — FA binds and neutralises reactive oxygen species. The review attributes this to FA’s oxygen-reactive binding capacity — consistent with the structural analysis in Rice-Evans 1996 (phenolic hydroxyl groups as the active antioxidant units).

Honest Conclusion

The review is notable for its cautious conclusion: FA is a promising pharmacological agent, but insufficient clinical evidence exists for standalone medical use. It is currently used experimentally as an adjunct to standard therapy. This honest assessment aligns with the editorial voice of this site — the evidence is real and mechanistically grounded, but clinical translation is still maturing.

fulvic-acidanti-inflammatoryantiallergicantioxidantwound-healingreview